Bioscience Journals Collection
2022年最新指标已更新Taylor & Francis 旗下拥有2700+本国际优质期刊,包含全部主要学科领域,为研究人员与学者提供高质量的综合学术交流平台。旗下的生物学期刊组合拥有230+ 国际期刊, 超30万篇同行评议文章,涵盖分子、细胞、生理、化学、医学等多个领域,拥有Autophagy, Molecular and Cellular Biology 等全球领先刊物。
Journals by Subjects
Cell Biology
Autophagy
Impact Factor: 13.3 (2022)
Q1
Autophagy publishes research on autophagic processes, to advance
understanding of the connection between autophagy and human health and
disease.
Molecular Biology
Molecular and Cellular Biology
Impact Factor: 5.3 (2022)
Q2
This journal covers advancements in research around the molecular biology of all eukaryotic cells. It includes gene expression and genome organization, and studies of chronic diseases and conditions.
RNA Biology
Impact Factor: 4.1 (2022)
Q2
Journal publishing cutting-edge research into RNA including RNA
sequencing, bioinformatics, structural biology, transcription and
splicing.
Journal Title | IF(2022) | Quartile | CiteScore(2022) |
---|---|---|---|
Critical Reviews In Biochemistry and Molecular Biology | 6.5 | Q1 | 13.5 |
Molecular and Cellular Biology | 5.3 | Q2 | 8.9 |
Expert Review of Molecular Diagnostics | 5.1 | Q1 | 6.9 |
Journal of Biomolecular Structure and Dynamics | 4.4 | Q1 | 9.1 |
RNA Biology | 4.1 | Q2 | 7.9 |
Epigenetics | 3.7 | Q2 | 7.7 |
Free Radical Research | 3.3 | Q3 | 7.2 |
Organogenesis | 2.3 | Q3 | 3.1 |
Biocatalysis and Biotransformation | 1.8 | Q4 | 4.6 |
Biotechnology & Applied Microbiology
Critical Reviews in Biotechnology
Impact Factor: 9.0 (2022)
Q1
Publishes on biotechnological techniques, including fermentation and genetic manipulation, relevant to fuel production and waste management industries.
Expert Opinion on Biological Therapy
Impact Factor: 4.6 (2022)
Q2
A MEDLINE-indexed journal dedicated to all aspects of biological therapy including gene therapy, gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, cell-based therapies, stem cell therapies, and tissue-based therapies. This journal offers accelerated publication
Journal Title | IF(2022) | Quartile | CiteScore 2022 |
---|---|---|---|
Critical Reviews in Biotechnology | 9.0 | Q1 | 17.5 |
Bioengineered | 4.9 | Q1 | 4.3 |
Expert Opinion on Biological Therapy | 4.6 | Q2 | 8.5 |
Biotechnology and Genetic Engineering Reviews | 3.2 | Q2 | 4.3 |
Biomarkers | 2.6 | Q3 | 4.5 |
Biofouling | 2.7 | Q1 | 6.0 |
Growth Factors | 1.8 | Q4 | 2.9 |
Electromagnetic Biology and Medicine | 1.7 | Q3 | 3.6 |
Biotechnology & Biotechnological Equipment | 1.4 | Q4 | 3.1 |
Life Science & Microbiology
Gut Microbes
Impact Factor: 12.2 (2022)
Q1
Gut Microbes publishes research on intestinal microbiota, and its role in gastrointestinal, liver, cardiac disease, cancer, and irritable and inflammatory bowel conditions.
All Life
Impact Factor: 1.2 (2022)
Focuses on life science research contributing to achieving the goals of ‘Zero Hunger,’ ‘Good Health and Well-being,’ ‘Life Below Water’ and ‘Life on Land.’
Journal Title | IF(2022) | Quartile | CiteScore(2022) |
---|---|---|---|
Gut Microbes | 12.2 | Q1 | 14.4 |
Critical Reviews in Microbiology | 6.5 | Q1 | 13.1 |
Virulence | 5.2 | Q2 | 7.3 |
Pathogens and Global Health | 3.4 | Q1 | 5.0 |
Prion | 2.3 | Q4 | 4.0 |
Communicative & Integrative Biology | 2.8 | ||
The Journal of Horticultural Science and Biotechnology | 1.9 | Q2 | 3.9 |
All Life | 1.2 | Q3 | 1.4 |
Journal of Histotechnology | 1.1 | Q4 | 2.4 |
All Life Methods |
Genetics
Mitochondrial DNA Part B
Impact Factor: 0.5 (2022)
Open-access research on mitochondrial DNA, particularly sequencing; rapid communications on its physical chemistry, biochemistry, metabolism and interactions.
Mitochondrial DNA Part A
Impact Factor:
Research on chemistry and biochemistry and mitochondrial DNA manipulation, proteins in mtDNA metabolism and/or interactions; cytosolic and extracellular mtDNA.
Epigenetics Reports
Impact Factor:
Publishes original research on all aspects of Epigenetics, including advances in epigenetic mechanisms and its regulation of biological and disease processes.
Impact Factor:
了解更多生物学及其他各学科高水平国际期刊,请访问 Taylor & Francis Group 旗下学术期刊网站, 欢迎相关学科研究人员向您青睐的杂志投稿。
期刊网站:www.tandfonline.com

Taylor & Francis 编辑润色服务
在准备向期刊提交稿件的时候,您需要协助吗? Taylor & Francis 编辑润色服务提供包括英语语言编辑、科学润色、翻译加编辑、稿件格式调整、相似度检查以及技术审核等,让您将时间集中在研究上。

为期刊、图书作者提供的实用指南
在您准备撰写一篇国际学术论文时,一个为您提供必要指导和资源实用网站可以为您解答许多疑问!从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导,写作投稿前的必看网站!

联系我们
Taylor & Francis Group拥有220多年的历史,是全球领先的学术出版集团,业务包括学术期刊、图书、电子书、教科书和参考书。以高质量的学术内容和服务水平,每年出版期刊2600余种,新书7000余册,累计图书出版量15万余册。旗下包括Routledge, CRC Press, Taylor & Francis等品牌,实现全学科均衡覆盖。我们整合数据、资源和技术优势,愿为中国研究人员和中国开放科学的发展提升,贡献更多的智慧和力量。